MedPath

Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke

Not Applicable
Recruiting
Conditions
Stroke
Registration Number
NCT01855633
Lead Sponsor
Dongtan Sacred Heart Hospital
Brief Summary

Stroke is one of the major causes of death in the World. Many stroke survivors may suffer from long-term sequelae of stroke such as hemiplegia. The effects of rehabilitation therapy are limited. The development of new treatment strategies is essential. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method to stimulate the focal area of the brain for restoring brain function. The aim of this study is to investigate the therapeutic effect of rTMS on the motor recovery in patients with hemiplegic stroke.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria
  • stroke patients with motor weakness
  • Medical research council (MRC) grade 0-4
  • More than 2 weeks after stroke onset
  • Age 18 years and older
  • Able to provide consent for the protocol
Exclusion Criteria
  • History of previous symptomatic stroke
  • pregnant women
  • Persons with surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), intracardiac lines that may pose a physical hazard during magnetic stimulation will also be excluded
  • Patients with history of seizure disorder or epilepsy
  • Subjects without the capacity to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Keyboard tapping test1 day

Participants will be asked to tap a key of a computer keyboard as fast as possible in five seconds. They will be asked to do three times. We will measure the number of tapping. The primary outcome will be the averaged data of the numbers.This will be done before and after 5-day rTMS intervention.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dongtan Sacred Heart Hospital

🇰🇷

Hwaseong Si, Gyeonggi-Do, Korea, Republic of

Dongtan Sacred Heart Hospital
🇰🇷Hwaseong Si, Gyeonggi-Do, Korea, Republic of
Suk Yun Kang, MD, PhD
Principal Investigator
Ah-Young Jun, MD, MS
Contact
82-31-8086-2310
ayjun@hallym.or.kr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.